Liver diseases: The epidemiology of hepatitis C virus infection

Journal of Clinical Gastroenterology

Volumn 36, Issue 1, 2003, Pages 47-53

  Yen, Tommy ^a   Keeffe, Emmet B ^b,c   Ahmed, Aijaz ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Hepatitis C virus; Transmission

Indexed keywords

ADULT; AGE DISTRIBUTION; BLOOD DONOR; BLOOD TRANSFUSION; DEMOGRAPHY; DISEASE TRANSMISSION; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL ACCIDENT; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; INCIDENCE; OCCUPATIONAL DISEASE; RENAL REPLACEMENT THERAPY; VIROLOGY;

DISEASE TRANSMISSION, VERTICAL; HEPATITIS C; HUMANS; INCIDENCE; OCCUPATIONAL DISEASES; ORGAN TRANSPLANTATION; PREVALENCE; RENAL DIALYSIS; RISK FACTORS;

EID: 0037213958     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200301000-00015     Document Type: Review

References (94)

1. Wasley A, Alter MJ. Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin Liver Dis 2000;20:1-16.
2. Third National Health and Nutrition Examination Survey (NHANES 111). National Center for Health Statistics (CD-ROM Catalog No. PB97-502959), United States, 1995. Hyattsville, Maryland: Public Health Service. 1996.
3. Alter MJ, Kruszon-Moran D, Nainon OV, et al. The prevalence of hepatitis C virus infection in United States, 1998 through 1994. N Engl J Med 1999;341: 556-62.
4. Armstrong GL, Alter MJ, McQuillan GM, et al. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States. Hepatology 2000;31:777-82.
5. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in posttransfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991;325:1325-9.
6. Koretz RL, Brezina M, Polito AJ, et al. Non-A, non-B posttransfusion hepatitis: Comparing C and non-C hepatitis. Hepatology 1993:17:361-5.
7. Alter MJ, Mares A, Hadler SC, et al. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 1987;125:133-9.
8. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26(suppl 1):62S-5S.
9. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus-(HCV) infection and HCV-related chronic disease. MMWR 1998:47:1-33.
10. Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis 1997;1:559-68.
11. WHO Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47.
12. Glynn SA, Kleinman SH, Schreiber GB. et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000;284:229-35.
13. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994;23:437-55.
14. Briggs ME, Baker C, Hall R, et al. Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology 2001;34:1200-5.
15. Hyams KC, Riddle J, Rubertone M, et al. Prevalence and incidence of hepatitis C virus infection in the US military: A seroepidemiologic survey of 21,000 troops. Am J Epidemiol 2001;153:764-70.
16. Ruiz JD, Molitor F, Sun RK, et al. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med 1999; 170:156-60.
17. Schwimmer JB, Balistreri WF. Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population. Semin Liver Dis 2000:20:37-46.
18. Thorpe LE, Ouellet LJ, Levy JR, et al. Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis 2000:182:1588-94.
19. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61.
20. Hagan H, Thiede H, Weiss NS, et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001;91:42-6.
21. Diaz T, Des Jarlais DC, Vlahov D, et al. Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 2001;91:23-30.
22. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-6.
23. Mattsson L, Aberg B, Weiland O, et al. Non-A, non-B hepatitis after open-heart surgery in Stockholm: Declining incidence after introduction of restrictions for blood donations due to the human immunodeficiency virus. Scand J Infect Dis 1988;20:371-6.
24. Blanchette VS, Vorstman E, Shore A. et al. Hepatitis C infection in children with hemophilia A and B. Blood 1991;78:285-9.
25. Bresee JS, Mast EE, Coleman PJ, et al. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA 1996:276:1563-7.
26. Rumi MG, Colombo M, Gringeri A, et al High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels. Ann Intern Med 1990; 112:379-80.
27. Mannucci PM, Schimpf K, Abe T, et al. Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group. Transfusion 1992:32:134-8.
28. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
29. Francis DP, Hadler SC, Prendergast TJ, et al. Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC sentinel county hepatitis stud3, 1. Am J Med 1984;76:69-74.
30. Alter MJ, Sampliner RE. Hepatitis C: And miles to go before we sleep. N Engl J Med 1989;321:1538-40.
31. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Lancet 1991;338:1040-1.
32. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-5.
33. Meyer RA, Gordon SC. Epidemiology of hepatitis C virus infection in a suburban Detroit community. Am J Gastroenterol 1991;86:1224-6.
34. Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90
35. Testing/preparing Blood for Patients. What Happens to Every Blood Donation. American Red Cross website. Available at: http://www.redcross.org/services/biomed/blood/supply/intro.html. Accessed May 18, 2002.
36. Dore GJ, Kaldor JM, McCaughan GW. Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ 1997;315:333-41.
37. Murphy EL, Bryzman S, Williams AE, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996;275:995-1000.
38. Busch MP, Wilber JC, Johnson P. et al. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992;32:420-5.
39. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
40. Pereira BJ, Milford EL, Kirkman RL, et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992;327:910-5.
41. Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997;51:981-99.
42. Rodriguez-Inigo E, Tomas JF, Gomez-Garcia de Soria V, et al at. Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: Results from a prospective study. Blood 1997;90:1326-31.
43. Lunel F, Cadranel JF, Rosenheim M, et al. Hepatitis virus infections in heart transplant recipients: Epidemiology, natural history, characteristics, and impact on survival. Gastroenterology 2000;119:1064-74.
44. Fabrizi F, Martin P. Hepatitis C virus infection in dialysis: An emerging clinical reality. Int J Artif Organs 2001;24:123-30.
45. Carvalho M, Branco PB, Luvizotto ML, et al. High prevalence of hepatitis C virus infection in chronic hemodialysis patients. Braz J Infect Dis 1999;3:144-8.
46. Zeldis JB, Depner TA, Kuramoto IK, et al. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 1990;112:958-60.
47. Fabrizi F, Lunghi G, Pagliari B, et al. Molecular epidemiology of hepatitis C virus infection in dialysis patients. Nephron 1997:77:190-6.
48. Seelig R, Renz M, Bottner C, et al. Hepatitis C virus infections in dialysis units: Prevalence of HCV-RNA and antibodies to HCV. Ann Med 1994;26:45-52.
49. Huang CC, Wu MS, Lin DY, et al. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992;12:31-3.
50. Allander T, Medin C, Jacobson SH, et al. Transmission of hepatitis C virus by transfer of an infected individual to a new dialysis unit. Nephron 1996:73:110.
51. Allander T, Medin C, Jacobson SH, et al. Hepatitis C transmission in a hemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994:43:415-9.
52. Lanphear BP, Linnemann CC Jr, Cannon CG, et al. Hepatitis C virus infection in healthcare workers: Risk of exposure and infection. Infect Control Hosp Epidemiol 1994;15:745-50.
53. Thomas DL, Factor SH, Kelen GD, et al. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 1993;153:1705-12.
54. Polish LB, Tong MJ, Co RL, et al. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993;21:196-200.
55. Cooper BW, Krusell A, Tilton RC. et al. Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol 1992;13:82-5.
56. Hofmann H, Kunz C. Low risk of health care workers for infection with hepatitis C virus. Infection 1990;18:286-8.
57. Haley RW, Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine 2001;80:134-51.
58. Thomas DL, Gruninger SE, Siew C, et al. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am J Med 1996;100:41-5.
59. Klein RS, Freeman K, Taylor PE, et al. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 1991;338:1539-42.
60. Shapiro CN, Tokars JI, Chamberland ME. Use of the hepatitis-B vaccine and infection with hepatitis B and C among orthopaedic surgeons. The American Academy of Orthopaedic Surgeons Serosurvey Study Committee. J Bone Joint Surg Am 1996;78:1791-800.
61. Panlilio AL, Shapiro CN, Schable CA, et al. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. J Am Coll Surg 1995; 180:16-24.
62. Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992;16:1109-14.
63. Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Am J Infect Control 1995;23:273-7.
64. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997;337:1485-90.
65. Sartori M, La Terra G, Aglietta M, et al. Transmission of hepatitis C via blood splash into conjunctiva. Scand J Infect Dis 1993;25:270-1.
66. Ippolito G, Puro V, Petrosillo N, et al. Simultaneous infection with HIV and hepatitis C virus following occupational conjunctival blood exposure. JAMA 1998;280:28.
67. Alter MJ, Coleman PJ, Alexander WJ, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989;262:1201-5.
68. Tedder RS, Gilson RJ, Briggs M, et al. Hepatitis C virus: Evidence for sexual transmission. BMJ 1991; 302:1299-302.
69. , Petersen EE, Clemens R, Bock HL, et al. Hepatitis B and C in heterosexual patients with various sexually transmitted diseases. Infection 1992;20:128-31.
70. Thomas DL, Zenilman JM, Alter HJ, et al. Sexual transmission of hepatitis C virus among patients attending attendin2 sexually transmitted diseases clinics in Baltimore: An analysis of 309 sex partnerships. J Infect Dis 1995;171:768-775.
71. Wu JC, Wang YJ, Hwang SJ, et al. Hepatitis D virus infection among prostitutes in Taiwan. J Gastroenterol Hepatol 1993;8:334-7.
72. Sanchez-Quijano A, Rey C, Aguado I. et al. Hepatitis C virus infection in sexually promiscuous groups. Eur J Clin Microbiol Infect Dis 1990;9:610-2.
73. Filippini P, Coppola N, Scolastico C, et al. Does HIV infection favor the sexual transmission of hepatitis C? Sex Transm Dis 2001:28:725-9.
74. Eyster ME, Alter HJ, Aledort LM, et al. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 1991;115:764-8.
75. Stevens CE. Perinatal and sexual transmission of hepatitis C virus: A preliminary report. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1991:407-10.
76. Zylberberg H, Thiers V, Lagorce D, et al. Epidemiological and virological analysis of couples infected with hepatitis C virus. Gut 1999;45:112-6.
77. Piazza M, Sagliocca L, Tosone G, et al. Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch Intern Med 1997;157:1537-44.
78. Akahane Y, Kojima M, Sugai Y, et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med 1994;120:748-52.
79. Leruez-Ville M, Kunstmann JM, De Almeida M, et al. Detection of hepatitis C virus in the semen of infected men. Lancet 2000;356:42-3.
80. Fried MW, Shindo M, Fong TL, et al. Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology 1992; 102:1306-8.
81. Tajiri H, Miyoshi Y, Funada S, et al. Prospective study of mother-to-infant transmission of hepatitis C virus. Pediatr Infect Dis J 2001;20:10-4.
82. Gibb DM, Goodall RL, Dunn DT, et al. Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission. Lancet 2000;356: 904-7.
83. Tajiri H, Miyoshi Y, Funada S, et al. Prospective study of mother-to-infant transmission of hepatitis C virus. Pediatr Infect Dis J 2001;20:10-4.
84. Thaler MM, Park CK, Landers DV, et al. Vertical transmission of hepatitis C virus. Lancet 1991;338:17-8.
85. Lin HH, Kao JH, Hsu HY, et al., Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 1994;169:638-41.
86. Lin HH, Kao JH, Hsu HY, et al. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996;87:244-8.
87. Kassem AS, el-Nawawy AA, Massoud MN, et al. Prevalence of hepatitis C virus (HCV) infection and its vertical transmission in Egyptian pregnant women and their newborns. J Trop Pediatr 2000;46:231-3.
88. Okamoto M, Nagata I, Murakami J, et al. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: High virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 2000; 182:1511-4.
89. Bortolotti F, Resti M, Giacchino R, et al. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr 1997;130:990-3.
90. Tumminelli F, Marcellin P, Rizzo S, et al. Shaving as potential source of hepatitis C virus infection. Lancet 1995;345:658.
91. Gabriel C, Blauhut B, Greul R, et al. Transmission of hepatitis C by ozone enrichment of autologous blood. Lancet 1996;347:541.
92. Sun DX, Zhang FG, Geng YQ, et al. Hepatitis C transmission by cosmetic tattooing in women. Lancet 1996;347:541.
93. Mele A, Corona R, Tosti ME, et al. Beauty treatments and risk of parenterally transmitted hepatitis: Results from the hepatitis surveillance system in Italy. Scand J Infect Dis 1995:27:441-4.
94. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-91.